ethyl gallate has been researched along with Cancer of Esophagus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode, AM; Chen, H; Dong, Z; Kim, DJ; Liu, F; Liu, K; Wang, T; Xie, X; Zheng, Y; Zu, X | 1 |
1 other study(ies) available for ethyl gallate and Cancer of Esophagus
Article | Year |
---|---|
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Proliferation; Enzyme Inhibitors; Esophageal Neoplasms; Female; Gallic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |